Genetic sequencing firm Illumina Inc. has formed a new company to develop a cancer-screening blood test, with investments from tech billionaires Bill Gates and Jeff Bezos. The new company, to be called Grail, has more than $100 million in funding from Illumina, Arch Venture Partners, Sutter Hill Ventures, Bezos Expeditions and Gates, according to a statement on Sunday. Grail’s goal is to create a “pan-cancer” screening test that can diagnose people at a very early stage even when they have no symptoms, said Jay Flatley, Illumina’s chief executive officer, in a telephone interview. “This is a massive market,” he said. “Depending on your assumptions, it’s somewhere between a $20 billion and $200 billion market opportunity.” As the startup’s name implies, such a test is a much-sought and elusive goal for the industry. Using a blood sample to screen for cancer is an increasingly popular idea because blood draws are far cheaper and less invasive than traditional biopsies. Good news for human beings, but I hate to say this: NOT GOOD for EXAS
LMAO replace give me a freakin break ! CG is a glorified stool test that hardly anybody gives a crap about. It is DOA already !
Yeah old news, most companies are there.. exas has identified emerging blood tests as a threat in their public business plan online.. Umm.. News flash .. "EXAS shares reportedly were weak due to the news that colon cancer test competitor Epigenomics expects FDA to decide on Epi proColon test in next few months"i
Hey Sparky! Maybe you should have read the whole article! “It remains to be proven,” Nelsen asserts, “but it’s likely to be the case that you will be able to know deep and large amounts of information about multiple cancers with a single test.” Maybe sometime in the future? But for now Cologuard is it.
What remains to be proven? There are better tests coming out that are blood based versus shit? I think this reas "FDA approval next few months" sparky.. You should apply
"And for now, this test doesn’t even really exist. Flatley is confident it will within a year. GRAIL has to talk to the FDA. It needs a CEO. Klausner, the former NCI chief, is leaving Illumina, but remaining with GRAIL as a director." Here ya go DA.... MAYBE you should have read the entire article!
It is positive though to be able to interpret and summarize the article several times, just the wrong one! Certainly Resorting to names like DA is childish. Just sharing competive info
Where have you been? Blood tests aren’t a new area of focus. We’re even working on them at Exact. CG has a limited window. We know it and will probably be the first company to come up with a replacement product. Not a surprise at all. Come back with actual news next time.
The constant acquisition of new companies is the only way to hide the underperformance. We can keep pretending the lack of profitability is due to the acquisition.